Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL677067 | 0.77 | MEN1 (0.39) | CYP2C9EPHX1EPHX2 | |
| SCHEMBL679325 | 0.72 | CYP2C9 (0.41) | CYP2C9EPHX1EPHX2 | |
| SCHEMBL6655791 | 0.72 | CYP2C9 (0.35) | CYP2C9EPHX1EPHX2 | |
| SCHEMBL1548216 | 0.72 | SLC22A2 (0.39) | CYP2C9EPHX1EPHX2 | |
| SCHEMBL25465432 | 0.72 | CYP2C9 (0.35) | CYP2C9EPHX1EPHX2 | |
| SCHEMBL19655057 | 0.70 | EPHX1 (0.33) | CYP2C9EPHX1EPHX2 | |
| SCHEMBL10882209 | 0.70 | EPHX1 (0.33) | CYP2C9EPHX1EPHX2 | |
| SCHEMBL14649672 | 0.69 | EPHX1 (0.33) | CYP2C9EPHX1EPHX2 | |
| SCHEMBL5410703 | 0.69 | EPHX1 (0.33) | CYP2C9EPHX1EPHX2 | |
| SCHEMBL24270380 | 0.67 | CYP2C9 (0.40) | CYP2C9EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6369101-B1 | Therapeutic method to treat herpes virus infection | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-04-09 | — | — | US | disclosed |
| WO-1998034603-A1 | USE OF BETULIN AND ANALOGS THEREOF TO TREAT HERPESVIRUS INFECTION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1998-08-13 | — | — | WO | disclosed |